1. Home
  2. IMNM vs BANC Comparison

IMNM vs BANC Comparison

Compare IMNM & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$22.12

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Banc of California Inc.

BANC

Banc of California Inc.

HOLD

Current Price

$21.16

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
BANC
Founded
2006
1941
Country
United States
United States
Employees
N/A
1904
Industry
Medicinal Chemicals and Botanical Products
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IMNM
BANC
Price
$22.12
$21.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
9
Target Price
$32.80
$21.83
AVG Volume (30 Days)
1.7M
2.7M
Earning Date
05-08-2026
04-22-2026
Dividend Yield
N/A
2.63%
EPS Growth
51.40
N/A
EPS
N/A
N/A
Revenue
$6,941,000.00
N/A
Revenue This Year
N/A
$13.93
Revenue Next Year
$1,127.34
$8.03
P/E Ratio
N/A
$17.08
Revenue Growth
N/A
N/A
52 Week Low
$8.67
$13.96
52 Week High
$27.65
$21.61

Technical Indicators

Market Signals
Indicator
IMNM
BANC
Relative Strength Index (RSI) 52.69 62.44
Support Level $19.28 $19.40
Resistance Level $23.25 $21.43
Average True Range (ATR) 1.36 0.42
MACD -0.03 0.02
Stochastic Oscillator 45.98 76.51

Price Performance

Historical Comparison
IMNM
BANC

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

Share on Social Networks: